Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Faes Farma Chooses Syrris Asia to Develop Continuous Flow Processes | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Faes Farma Chooses Syrris Asia to Develop Continuous Flow Processes

Acquired a Syrris Asia system in early 2018 with the aim of developing a new synthetic pathway for an existing API.

By: Contract Pharma

Contract Pharma Staff

Faes Farma, a Spanish pharmaceutical company headquartered near Bilbao, is using a Syrris Asia Flow Chemistry System to develop novel synthesis pathways for new and existing active pharmaceutical ingredients (APIs).
 
“We are interested in using flow chemistry to allow us to perform reactions that would be too dangerous in a batch set-up, because they are either very exothermic or involve highly corrosive media,” said Pablo Morán, a chemical innovation scientist in Faes Farma’s R&D department.
 
Faes Farma acquired a Syrris Asia system in early 2018 with the aim of developing a new synthetic pathway for an existing API and said it was quickly able to set up the Asia system to perform this study, rapidly working through numerous conditions and concentrations.
 
“It is straightforward to control the various modules either directly or, for more complex experimental set-ups, via the PC software,” said Morán. “We have also been able to introduce a number of third-party devices to the continuous flow process as required. This gives us the flexibility to accommodate almost any synthesis process, and we will certainly be exploring this option for the development of new synthesis pathways in the future. It’s a useful tool to have.”
 

 
 
                                                                                                                       

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics